xRead - Nasal Obstruction (September 2024) Full Articles

20426984, 0, Downloaded from https://onlinelibrary.wiley.com/doi/10.1002/alr.23262, Wiley Online Library on [02/01/2024]. See the Terms and Conditions (https://onlinelibrary.wiley.com/terms-and-conditions) on Wiley Online Library for rules of use; OA articles are governed by the applicable Creative Commons License

429

ICAR SINONASAL TUMORS

1394. Morand GB, Anderegg N, Vital D, et al. Outcome by treatment modality in sinonasal undifferentiated carcinoma (SNUC): a case-series, systematic review and meta-analysis. Oral Oncol . 2017;75:28-34. https://doi.org/10.1016/j.oraloncology. 2017.10.008 1395. Workman AD, Brody RM, Kuan EC, et al. Sinonasal undiffer entiated carcinoma: a 15-year single institution experience. J Neurol Surg Part B . 2019;80(1):88-95. https://doi.org/10.1055/s 0038-1668537 1396. Rodriguez CP, Liao JJ, Liu AW, et al. Patterns of recurrence in patients with sinonasal undifferentiated carcinoma (SNUC) treated with multimodality therapy at a single center. J Clin OncolConf . 2017;35(15_suppl):e17575. 1397. Lopez F, Suarez V, Vivanco B, Suarez C, Llorente JL. Cur rent management of sinonasal undifferentiated carcinoma. Rhinology . 2015;53(3):212-220. https://doi.org/10.4193/Rhin14. 054 1398. Jo VY, Chau NG, Hornick JL, Krane JF, Sholl LM. Recur rent IDH2 R172X mutations define sinonasal undifferentiated carcinoma. ModPathol . 2017;30(5):650-659. https://doi.org/10. 1038/modpathol.2016.239 1399. Dogan S, Chute DJ, Xu B, et al. Frequent IDH2 R172 mutations in undifferentiated and poorly-differentiated sinonasal carci nomas. JPathol . 2017;242(4):400-408. https://doi.org/10.1002/ path.4915 1400. Dogan S, Frosina D, Geronimo JA, et al. Molecular epidemi ology of IDH2 hotspot mutations in cancer and immuno histochemical detection of R172K, R172G, and R172M vari ants. Hum Pathol . 2020;106:45-53. https://doi.org/10.1016/j. humpath.2020.09.013 1401. Elkhatib AH, Soldatova L, Carrau RL, et al. Role of F-18-FDG PET/CT differentiating olfactory neurob lastoma from sinonasal undifferentiated carcinoma. Laryngoscope . 2017;127(2):321-324. https://doi.org/10.1002/ lary.26194 1402. Kuo P, Manes RP, Schwam ZG, Judson BL. Survival outcomes for combined modality therapy for sinonasal undifferentiated carcinoma. Otolaryngol Head Neck Surg . 2017;156(1):132-136. https://doi.org/10.1177/0194599816670146 1403. Amit M, Abdelmeguid AS, Watcherporn T, et al. Induction chemotherapy response as a guide for treatment optimiza tion in sinonasal undifferentiated carcinoma. J Clin Oncol . 2019;37(6):504-512. https://doi.org/10.1200/JCO.18.00353 1404. van der Laan TP, Iepsma R, Witjes MJ, van der Laan BF, Plaat BE, Halmos GB. Meta-analysis of 701 published cases of sinonasal neuroendocrine carcinoma: the importance of differentiation grade in determining treatment strategy. OralOncol . 2016;63:1-9. https://doi.org/10.1016/j.oraloncology. 2016.10.002 1405. Chambers KJ, Lehmann AE, Remenschneider A, et al. Inci dence and survival patterns of sinonasal undifferentiated carcinoma in the United States. J Neurol Surg B Skull Base . 2015;76(2):94-100. https://doi.org/10.1055/s-0034-1390016 1406. Chen AM, Daly ME, El-Sayed I, et al. Patterns of failure after combined-modality approaches incorporating radiother apy for sinonasal undifferentiated carcinoma of the head and neck. Int J Radiat Oncol Biol Phys . 2008;70(2):338-343. https:// doi.org/10.1016/j.ijrobp.2007.06.057

1381. Sun M, Wang K, Qu Y, et al. Proposal of a TNM classification based staging system for esthesioneuroblastoma: more pre cise prediction of prognosis. HeadNeck . 2021;43(4):1097-1104. https://doi.org/10.1002/hed.26559 1382. Yang J, Song X, Lai Y, et al. Development and validation of a postoperative nomogram for predicting overall survival after endoscopic surgical management of olfactory neuroblastoma. eClinicalMedicine . 2020;29-30:100577. https://doi.org/10.1016/ j.eclinm.2020.100577 1383. Carey RM, Godovchik J, Workman AD, et al. Patient, disease, and treatment factors associated with overall survival in esthe sioneuroblastoma: factors associated with ENB survival. Int Forum Allergy Rhinol . 2017;7(12):1186-1194. https://doi.org/10. 1002/alr.22027 1384. Konuthula N, Iloreta AM, Miles B, et al. Prognostic signifi cance of Kadish staging in esthesioneuroblastoma: an analysis of the National Cancer Database. HeadNeck . 2017;39(10):1962 1968. https://doi.org/10.1002/hed.24770 1385. Song X, Wang J, Wang S, Yan L, Li Y. Prognostic factors and outcomes of multimodality treatment in olfactory neuroblas toma. Oral Oncol . 2020;103:104618. https://doi.org/10.1016/j. oraloncology.2020.104618 1386. Marinelli JP, Janus JR, Van Gompel JJ, et al. Esthesioneu roblastoma with distant metastases: systematic review & meta-analysis. HeadNeck . 2018;40(10):2295-2303. https://doi. org/10.1002/hed.25209 1387. Vuong HG, Nguyen DD, El-Rassi E, Ngo TNM, Dunn IF. Absence of survival improvement for patients with esthe sioneuroblastoma over the past 2 decades: a population-based study. World Neurosurg . 2022;157:e245-e253. https://doi.org/ 10.1016/j.wneu.2021.09.139 1388. Wang J, Wang L, He H, Li Y, Song X. The treatment out comes of olfactory neuroblastoma patients with frontal lobe invasion. Front Oncol . 2021;11:640892. https://doi.org/10.3389/ fonc.2021.640892 1389. Miller KC, Marinelli JP, Van Gompel JJ, et al. Utility of adju vant chemotherapy in patients receiving surgery and adjuvant radiotherapy for primary treatment of esthesioneuroblastoma. Head Neck . 2019;41(5):1335-1341. https://doi.org/10.1002/hed. 25558 1390. Frierson HF, Mills SE, Fechner RE, Taxy JB, Levine PA. Sinonasal undifferentiated carcinoma. An aggressive neoplasm derived from Schneiderian epithelium and dis tinct from olfactory neuroblastoma. Am J Surg Pathol . 1986;10(11):771-779. 1391. Agaimy A, Franchi A, Lund VJ, et al. Sinonasal undif ferentiated carcinoma (SNUC): from an entity to morpho logic pattern and back again—a historical perspective. Adv Anat Pathol . 2020;27(2):51-60. https://doi.org/10.1097/PAP. 0000000000000258 1392. Libera L, Ottini G, Sahnane N, et al. Methylation drivers and prognostic implications in sinonasal poorly differenti ated carcinomas. Cancers . 2021;13(19):5030. https://doi.org/10. 3390/cancers13195030 1393. Vaziri Fard E, Zhang S, Cai Z, et al. Sinonasal undifferentiated carcinoma: clinicopathological spectrums and diagnosis reap praisal. Hum Pathol . 2019;89:62-70. https://doi.org/10.1016/j. humpath.2019.04.008